Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses. (2021)
Attributed to:
nCoV: Developing CoV-bnMABs for therapy of highly pathogenic coronaviruses including SARS-CoV-2
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/v13081579
PubMed Identifier: 34452443
Publication URI: http://europepmc.org/abstract/MED/34452443
Type: Journal Article/Review
Volume: 13
Parent Publication: Viruses
Issue: 8
ISSN: 1999-4915